Company intelligence / Profile preview

Drew Scientific Group

Miami, Florida, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Drew Scientific Group is a global medical diagnostics company specializing in the design and manufacture of analytical instruments and reagents for the healthcare market. The company focuses primarily on hematology and diabetes monitoring, offering well-known systems such as the DS5 for HbA1c testing and the Excel series for hematology analysis. As a subsidiary of Erba Mannheim, Drew Scientific provides high-quality diagnostic solutions to laboratories, clinics, and hospitals worldwide. Their product portfolio includes automated cell counters, HPLC systems, and a comprehensive range of consumables designed to improve patient outcomes through precise testing.

Therapeutic areas: HematologyEndocrinology
Modalities: Device
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Drew Scientific Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drew Scientific Group.

Explore the full profile